Literature DB >> 26438019

A 29-year-old woman with Crohn disease considering pregnancy.

Vivian Huang1, Richard Fedorak2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26438019      PMCID： PMC4732963          DOI： 10.1503/cmaj.150640

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  A prospective study of the safety of lower gastrointestinal endoscopy during pregnancy in patients with inflammatory bowel disease.

Authors:  A de Lima; Z Zelinkova; C J van der Woude
Journal:  J Crohns Colitis       Date:  2015-05-04       Impact factor: 9.071

2.  Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity.

Authors:  Severine Vermeire; Stefan Schreiber; William J Sandborn; Cécile Dubois; Paul Rutgeerts
Journal:  Clin Gastroenterol Hepatol       Date:  2010-01-21       Impact factor: 11.382

Review 3.  The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease.

Authors:  C J van der Woude; S Ardizzone; M B Bengtson; G Fiorino; G Fraser; K Katsanos; S Kolacek; P Juillerat; A G M G J Mulders; N Pedersen; C Selinger; S Sebastian; A Sturm; Z Zelinkova; F Magro
Journal:  J Crohns Colitis       Date:  2015-02       Impact factor: 9.071

4.  Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety.

Authors:  A de Lima; Z Zelinkova; C van der Ent; E A P Steegers; C J van der Woude
Journal:  Gut       Date:  2015-05-12       Impact factor: 23.059

5.  Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease.

Authors:  A Abhyankar; M Ham; A C Moss
Journal:  Aliment Pharmacol Ther       Date:  2013-07-15       Impact factor: 8.171

6.  Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.

Authors:  S Mozaffari; A H Abdolghaffari; S Nikfar; M Abdollahi
Journal:  Hum Exp Toxicol       Date:  2014-11-05       Impact factor: 2.903

Review 7.  The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics.

Authors:  Uma Mahadevan; Salvatore Cucchiara; Jeffrey S Hyams; Flavio Steinwurz; F Nuti; Simon P L Travis; William J Sandborn; Jean-Frederio Colombel
Journal:  Am J Gastroenterol       Date:  2010-12-14       Impact factor: 10.864

Review 8.  Biomarkers of Inflammation in Inflammatory Bowel Disease.

Authors:  Bruce E Sands
Journal:  Gastroenterology       Date:  2015-07-09       Impact factor: 22.682

9.  Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure.

Authors:  Gabriella Bröms; Fredrik Granath; Marie Linder; Olof Stephansson; Maria Elmberg; Helle Kieler
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

10.  Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study.

Authors:  L Ban; L J Tata; D J Humes; L Fiaschi; T Card
Journal:  Aliment Pharmacol Ther       Date:  2015-08-06       Impact factor: 9.524
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.